Category Ranking
98%
Total Visits
921
Avg Visit Duration
2 minutes
Citations
20
Article Abstract
The myocardial fibrosis leading to cardiac remodelling is a key factor in the progression of chronic heart failure. The present study aims to investigate the mechanism of canagliflozin's improvement of cardiac fibrosis in chronic heart failure rats and the effect of dose on efficacy. Chronic heart failure models were established by intraperitoneal injection of isoproterenol to rats for 10 days. The rats were then randomised into five groups: control rats, chronic heart failure rats, rats treated with a low dose of canagliflozin, rats treated with a high dose of canagliflozin and rats treated with enalapril. Canagliflozin was administered once daily for 4 weeks by gastric feeding. The rats were then euthanised after cardiac function analysis by echocardiography. Detection of chronic heart failure markers from serum was performed using enzyme-linked immunosorbent assay kits. The tissue sections were examined by histological staining to assess the cardioprotective effect of canagliflozin in chronic heart failure rats. Myocardial interstitial fibrosis was evaluated by specific immunostaining. The control, chronic heart failure and low dose of canagliflozin groups were sequenced and analysed to identify differentially expressed genes, and the expression of selected genes was verified by qRT-PCR. Echocardiographic measurements provided evidence supporting the ability of canagliflozin to improve cardiac function. Canagliflozin treatment reduced the chronic heart failure marker N-terminal pro-B-type natriuretic peptide. HE staining and Masson's trichrome staining demonstrated that canagliflozin effectively reduced collagen deposition and alleviated myocardial fibrosis. The immunohistochemical staining revealed that treatment with canagliflozin inhibited the expression of fibrosis markers Collagen I, Collagen III and fibronectin 1. The differentially expressed genes identified through RNA sequencing were found to be enriched in the ECM-receptor interaction pathway. The results of qRT-PCR demonstrated that canagliflozin reduced the level of differentially expressed genes involving collagen type I alpha 1 chain, collagen type I alpha 2 chain, collagen type III alpha 1 chain and fibronectin 1. Interestingly, the results did not show a trend toward better efficacy of high-dose compared with low-dose canagliflozin in the treatment of chronic heart failure. In summary, canagliflozin could directly improve myocardial fibrosis to control the progression of chronic heart failure. Canagliflozin may not be dose-dependent in the treatment of chronic heart failure.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC12335939 | PMC |
| http://dx.doi.org/10.1111/jcmm.70718 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Quantifying Exercise Intensity to Predict Changes in Walking Capacity in People with Chronic Stroke.
Arch Phys Med Rehabil
September 2025
Department of Physical Therapy, University of Delaware, Newark, DE, USA; Biomechanics and Movement Science Program, University of Delaware, Newark, DE, USA. Electronic address:
Objective: To examine if exercise intensity, quantified as heart rate or training speed, predicts walking outcomes in people with chronic stroke.
Design: This is a secondary analysis from a larger randomized clinical trial ("PROWALKS"; NIH1R01HD086362).
Setting: Four, outpatient rehabilitation clinics.
Development and validation of a prognostic model for predicting the risk of allopurinol-induced severe cutaneous adverse reactions: a retrospective new-user cohort study using linked primary care, hospitalisation, and mortality data.
Lancet Rheumatol
September 2025
Academic Rheumatology, University of Nottingham, Nottingham, UK.
Background: Allopurinol, the most prescribed urate-lowering drug, is a known cause of severe cutaneous adverse reactions. We aimed to develop and validate a model to assess the risk of allopurinol-induced severe cutaneous adverse reactions in adults newly prescribed allopurinol.
Methods: In this retrospective new-user cohort study, we developed and validated a prognostic model using primary care, hospitalisation, and mortality data extracted from the UK Clinical Practice Research Datalink (CPRD) primary care database, for the period Jan 1, 2001, to March 29, 2021.
Application of computer vision for automated detection of different lesions in pig lungs: An exploratory study.
Prev Vet Med
September 2025
Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia Romagna 'Bruno Ubertini' (IZSLER), Via Bianchi 7/9, Brescia 25124, Italy. Electronic address:
Accurate classification of lung lesions at necropsy is crucial for guiding the diagnostic process and ensuring effective management of porcine respiratory diseases. Post-mortem inspection of the lungs during slaughter also provides valuable insights into disease occurrence, offering useful feedback on the efficacy of on-farm prevention and control strategies. However, manual assessment protocols may be impaired by high slaughtering speeds and low inter-rater agreement, which limits continuous data collection and hinders comparability.
View Article and Find Full Text PDFPerioperative glucagon-like Peptide-1 receptor agonist use and clinical outcomes following lower extremity fracture fixation: A large retrospective cohort study with two year follow up.
Injury
September 2025
Washington University School of Medicine, Department of Orthopaedic Surgery, St. Louis, MO, USA. Electronic address:
Introduction: Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are increasingly prescribed for Type 2 diabetes and obesity due to their cardiometabolic benefits. However, their effects on fracture healing remain controversial. This study investigates perioperative GLP-1 RA use and outcomes following surgical treatment of lower extremity (LE) fractures.
View Article and Find Full Text PDFSpatial heterogeneity and distribution of CT-Based pulmonary vascular volumes in chronic thromboembolic pulmonary hypertension.
Eur J Radiol
September 2025
Division of Pulmonary and Critical Care Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.
Rationale/objectives: Image-based vascular biomarkers may help expedite evaluation of chronic thromboembolic pulmonary hypertension (CTEPH), which remains difficult to diagnose despite available effective therapies. We sought to determine if vascular heterogeneity and central redistribution on chest CT differed between CTEPH, pulmonary arterial hypertension (PAH), and control groups.
Materials/methods: We retrospectively included 108 patients who underwent right heart catheterization and chest CT (2011-2018).